June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Widefield Swept-Source OCT Angiography (WF SS-OCTA) Vascular Metrics as Biomarkers for Renal Function in Diabetes Mellitus (DM) Patients
Author Affiliations & Notes
  • Itika Garg
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Margaret Duich
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Chibuike Uwakwe
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Edward S Lu
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Karen Michelle Wai
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ying Cui
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Ophthalmology, Guangdong Medical University, Guangzhou, Guangdong, China
  • Rongrong Le
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Rebecca Zeng
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Raviv Katz
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Ying Zhu
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Ophthalmology, Xiangya Hospital Central South University, Changsha, Hunan, China
  • Leo A Kim
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • David M Wu
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Nimesh A. Patel
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • John B Miller
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Itika Garg None; Margaret Duich None; Chibuike Uwakwe None; Edward Lu None; Karen Wai None; Ying Cui None; Rongrong Le None; Rebecca Zeng None; Raviv Katz None; Ying Zhu None; Leo Kim National Eye Institute, CureVac AG, Code F (Financial Support), Pykus Therapeutics, Code I (Personal Financial Interest), Pykus Therapeutics, Code S (non-remunerative); David Wu Massachusetts Eye and Ear, Code P (Patent); Nimesh Patel Alimera Sciences, Alcon, Allergan, and Genentech, Code C (Consultant/Contractor); Deeba Husain Allergan, Genetech, Omeicos Therapeutics, Code C (Consultant/Contractor), National Eye Institute, Lions VisionGift, Commonwealth Grant, Lions International, Syneos LLC, and the Macular Society, Code F (Financial Support); Demetrios Vavvas Valitor, Olix Pharmaceuticals, Code C (Consultant/Contractor), National Eye Institute and by grants from the National Institute of Health (R01EY025362 and R21EY0203079), Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, and Alcon Research Institute, Code F (Financial Support); John Miller Alcon, Allergan, Carl Zeiss, Sunovion and Genentech, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2929 – F0082. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Itika Garg, Margaret Duich, Chibuike Uwakwe, Edward S Lu, Karen Michelle Wai, Ying Cui, Rongrong Le, Rebecca Zeng, Raviv Katz, Ying Zhu, Leo A Kim, David M Wu, Nimesh A. Patel, Deeba Husain, Demetrios G. Vavvas, John B Miller; Widefield Swept-Source OCT Angiography (WF SS-OCTA) Vascular Metrics as Biomarkers for Renal Function in Diabetes Mellitus (DM) Patients. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2929 – F0082.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Microvascular complications of DM (retinopathy, nephropathy and neuropathy) are closely interrelated and are an important cause of patient morbidity and mortality. We aim to evaluate the relationship between WF SS-OCTA quantitative metrics and the presence of albuminuria and serum creatinine in DM patients.

Methods : In this cross-sectional observational study between January 2019 and April 2021, 380 eyes of 234 patients were imaged on 100kHz WF SS-OCTA using 12x12mm angiogram centered on fovea. The ARI Network (Zeiss Portal) was used to calculate vessel density (VD), vessel skeletonized density (VSD), foveal avascular zone area, circularity, and perimeter; and ImageJ for non-perfusion area (NPA), Figure 1. We recorded glycosylated hemoglobin (HbA1c), serum urea, creatinine and urine albumin to creatinine ratio (ACR) within one year of imaging.

Results : The median patient age was 58.5 (50-65) years and 125 (53.4%) were males. Subjects had a median HbA1c 8.1 (7-9.3) %, median creatinine 0.98 (0.80-1.33) mg/dL and 111 (47.4%) patients had albuminuria (urine ACR >30mg/g). Using serum creatinine, estimated glomerular filtration rate (eGFR) was calculated, and 74 (31.6%) patients had chronic diabetic kidney disease (CDKD) i.e., eGFR <60mL/min/1.73m2 (Figure 2). Using mixed effects multiple logistic regression model adjusting for age, smoking status, HbA1c, mean arterial blood pressure and duration of diabetes; NPA (Odd’s ratio (OR)=1.14, 1.03-1.27; p=0.02) and whole retina VSD (OR=0.26, 0.08-0.10; p=0.02) were significantly associated with the presence of albuminuria. None of the OCTA metrics were significantly associated with serum creatinine. Also, NPA (OR=1.11, 1.00-1.23, p=0.047) and superficial VSD (OR=0.61, 0.37-0.99, p=0.047) were significant predictors for the presence of CDKD.

Conclusions : Herein, we see that NPA can serve as a potential imaging biomarker associated with deteriorating renal function (presence of albuminuria and CDKD). Due to OCTA having high-resolution and being depth resolved, quantitative OCTA metrics can leverage the changes at the retinal capillary level in patients with kidney damage. Hence, this safe non-invasive device can be potentially useful for diagnosis and early management of various microvascular complications of DM.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

WF SS-OCTA metrics analyzed

WF SS-OCTA metrics analyzed

 

Boxplots comparing WF SS-OCTA metrics in DM patients with and without nephropathy

Boxplots comparing WF SS-OCTA metrics in DM patients with and without nephropathy

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×